Phase I Study GX-G3 in Healthy Subjects

Conditions

• Healthy

Interventions

• DRUG: GX-G3 12.5 μg/kg or Placebo
• DRUG: GX-G3 25 μg/kg or Placebo
• DRUG: GX-G3 50 μg/kg or Placebo
• DRUG: GX-G3 100 μg/kg or Placebo

Sponsor

Genexine, Inc.